Role of Nicotinamide Quinone Oxidoreductase 1 (NQO1) in Protection against Toxicity of Electrophiles and Reactive Oxygen Intermediates

Methods in Enzymology

Volumn 382, Issue , 2004, Pages 355-364

  Talalay, Paul ^a,b   Dinkova Kostova, Albena T ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BENZOQUINONE; ANTINEOPLASTIC AGENT; NICOTINAMIDE DERIVATIVE; NICOTINAMIDE QUINONE OXIDOREDUCTASE I; OXIDOREDUCTASE; QUINONE DERIVATIVE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ARTICLE; DNA RESPONSIVE ELEMENT; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME ISOLATION; ENZYME REGULATION; GENE DISRUPTION; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION; TOXICITY;

EID: 1242274624     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(04)82019-6     Document Type: Article

References (58)

1. L. Ernster and F. Navazio, Acta. Chem. Scand. 12, 595 (1958).
2. F. Märki and C. Martius, Biochem. J. 333, 111 (1960).
3. H. J. Prochaska and P. Talalay, in "Oxidative Stress: Oxidants and Antioxidants" (H. Sies, ed.), Academic Press, London, 1991.
4. A. T. Dinkova-Kostova and P. Talalay, Free Rad. Biol. Med. 29, 231 (2000).
5. H. G. Williams-Ashman and C. Huggins, Med. Exper. 4, 223 (1961).
6. C. Lind, H. Vadi, and L. Ernster, Arch. Biochem. Biophys. 190, 97 (1978).
7. C. B. Huggins, in "Experimental leukemia and mammary cancer: induction, prevention, cure," The University of Chicago Press, Chicago, 1979.
8. C. Huggins and R. Fukunishi, J. Exp. Med. 119, 923 (1964).
9. C. Huggins and J. Pataki, Proc. Natl. Acad. Sci. USA 53, 791 (1965).
10. L. W. Wattenberg, Adv. Cancer Res. 26, 197 (1979).
11. R. P. Batzinger, S.-Y. L. Ou, and E. Bueding, Cancer Res. 38, 4478 (1978).
12. A. M. Benson, R. P. Batzinger, S.-Y. L. Ou, E. Bueding, Y.-N. Cha, and P. Talalay, Cancer Res. 38, 4486 (1978).
13. A. M. Benson, Y.-N. Cha, E. Bueding, H. S. Heine, and P. Talalay, Cancer Res. 39, 2971 (1979).
14. P. Talalay, J. W. Fahey, W. D. Holtzclaw, T. Prestera, and Y. Zhang, Toxicol. Letts. 82/83, 173 (1995).
15. P. Talalay, BioFactors 12, 5 (2000).
16. W. R. Pearson, J. J. Windle, J. F. Morrow, A. M. Benson, and P. Talalay, J. Biol. Chem. 258, 2052 (1983).
17. A. M. Benson, M. J. Hunkeler, and P. Talalay, Proc. Natl. Acad. Sci. USA 77, 5216 (1980).
18. C. Lind, P. Hochstein, and L. Ernster, Arch. Biochem. Biophys. 216, 178 (1982).
19. P. L. Chesis, D. E. Levin, M. T. Smith, L. Ernster, and B. N. Ames, Proc. Natl. Acad. Sci. USA 81, 1696 (1984).
20. H. Wefers, T. Komai, P. Talalay, and H. Sies, FEBS Lett. 169, 63 (1984).
21. H. J. Prochaska and P. Talalay, J. Biol. Chem. 261, 1372 (1986).
22. L. M. Amzel, S. H. Bryant, H. J. Prochaska, and P. Talalay, J. Biol. Chem. 261, 1370 (1986).
23. H. J. Prochaska, P. Talalay, and H. Sies, J. Biol. Chem. 262, 1931 (1987).
24. H. J. Prochaska and A. B. Santamaria, Anal. Biochem. 169, 328 (1988).
25. H. J. Prochaska, A. B. Santamaria, and P. Talalay, Proc. Natl. Acad. Sci. USA 89, 2394 (1992).
26. M. J. De Long, H. J. Prochaska, and P. Talalay, Proc. Natl. Acad. Sci. USA 83, 787 (1986).
27. J. W. Fahey, A. T. Dinkova-Kostova, K. K. Stephenson, and P. Talalay, Methods Enzymol. 382, 243 (2004).
28. Y. Zhang, P. Talalay, C.-G. Cho, and G. H. Posner, Proc. Natl. Acad. Sci. USA 89, 2399 (1992).
29. J. W. Fahey, Y. Zhang, and P. Talalay, Proc. Natl. Acad. Sci. USA 94, 10367 (1997).
30. J. Pezzuto and Y.-H. Kang, Methods Enzymol. 382, 380 (2004).
31. G. H. Posner, C.-G. Cho, J. V. Green, Y. Zhang, and P. Talalay, J. Med. Chem. 37,170 (1994).
32. C. Gerhäuser, M. You, J. Liu, R. M. Moriarty, M. Hawthorne, R. J. Mehta, R. C. Moon, and J. M. Pezzuto, Cancer Res. 57, 272 (1997).
33. P. A. Egner, T. W. Kensler, T. Prestera, P. Talalay, A. H. Libby, H. H. Joyner, and T. J. Curphey, Carcinogenesis 15, 177 (1994).
34. A. T. Dinkova-Kostova and P. Talalay, Carcinogenesis 20, 911 (1999).
35. L. V. Favreau and C. B. Pickett, J. Biol. Chem. 268, 19875 (1993).
36. T. Nguyen, P. J. Sherratt, and C. B. Pickett, Annu. Rev. Pharmacol. Toxicol. 43, 233 (2003).
37. V. Radjendirane, P. Joseph, Y. H. Lee, S. Kimura, A. J. Klein-Szanto, F. J. Gonzalez, and A. K. Jaiswal, J. Biol. Chem. 273, 7382 (1998).
38. D. J. Long 2nd, R. L. Waikel, X.-J. Wang, L. Perlaky, D. R. Roop, and A. K. Jaiswal, Cancer Res. 60, 5913 (2000).
39. D. J. Long 2nd, R. L. Waikel, X.-J. Wang, D. R. Roop, and A. K. Jaiswal, J. Natl. Cancer Inst. 93, 1166 (2001).
40. Y. H. Edwards, J. Potter, and D. A. Hopkinson, Biochem. J. 187, 429 (1980).
41. D. Ross, J. K. Kepa, S. L. Winski, H. D. Beall, A. Anwar, and D. Siegel, Chem.-Biol. Interactions 129, 77 (2000).
42. D. Ross and D. Siegel, Methods Enzymol. 382, 115 (2004).
43. D. W. Nebert, A. L. Roe, S. E. Vandale, E. Bingham, and G. G. Oakley, Genet. Med. 4, 62 (2002).
44. W. A. Schulz, A. Krummeck, I. Rosinger, P. Eickelman, C. Neuhaus, T. Ebert, B. J. Schmitz-Drager, and H. Sies, Pharmacogenetics 7, 235 (1997).
45. A. Clairmont, H. Sies, S. Ramachandran, J. T. Lear, A. G. Smith, B. Bowers, P. W. Jones, A. A. Fryer, and R. C. Strange, Carcinogenesis 20, 1235 (1999).
46. J. Zhang, W. A. Schulz, Y. Li, R. Wang, R. Zotz, D. Wen, D. Siegel, D. Ross, H. E. Gabbert, and M. Sarbia, Carcinogenesis 24, 905 (2003).
47. M. J. Lafuente, X. Casterad, M. Trias, C. Ascaso, R. Molina, A. Ballesta, S. Zheng, J. K. Wiencke, and A. Lafuente, Carcinogenesis 21, 1813 (2000).
48. H. Chen, A. Lum, A. Seifried, L. R. Wilkens, and L. Le Marchand, Cancer Res. 59, 3045 (1999).
49. S. J. Lewis, N. M. Cherry, R. M. Niven, P. V. Barber, and A. C. Povey, Lung Cancer 34, 177 (2001).
50. N. Rothman, M. T. Smith, R. B. Hayes, R. D. Traver, B. Hoener, S. Campleman, G. L. Li, M. Dosemeci, M. Linet, L. Zhang, L. Xi, S. Wacholder, W. Lu, K. B. Meyer, N. Titenko-Holland, J. T. Stewart, S. Yin, and D. Ross, Cancer Res. 57, 2839 (1997).
51. M. T. Smith, Proc. Natl. Acad. Sci. USA 96, 7624 (1999).
52. R. A. Larson, Y. Wang, M. Banerjee, J. Wiemels, C. Hartford, M. M. Le Beau, and M. T. Smith, Blood 94, 803 (1999).
53. J. L. Wiemsels, A. Pagnamenta, G. M. Taylor, O. B. Eden, F. E. Alexander, and M. F. Greaves, Cancer Res. 59, 4095 (1999).
54. M. Krajinovic, D. Labuda, G. Mathonnet, M. Labuda, A. Moghrabi, J. Champagne, and D. Sinnett, Clin. Cancer Res. 8, 802 (2002).
55. M. T. Smith, Y. Wang, C. F. Skibola, D. J. Slater, L. Lo Nigro, P. C. Nowell, B. J. Lange, and C. A. Felix, Blood 100, 4590 (2002).
56. G. Asher, J. Lotem, R. Kama, L. Sachs, and Y. Shaul, Proc. Natl. Acad. Sci. USA 99, 3099 (2002).
57. G. Asher, J. Lotem, L. Sachs, C. Kahana, and Y. Shaul, Proc. Natl. Acad. Sci. USA 99, 13125 (2002).
58. A. Andwar, D. Dehn, D. Siegel, J. K. Kepa, L. J. Tang, J. A. Pietenpol, and D. Ross, J. Biol. Chem. 278, 10368 (2003).